AB Intl Health Care I GBP
Healthcare and BiotechnologyPricing frequency
Daily
Dealing cut off time
17:00
Type
SICAV
Yield
–
NAV
£29.18
Income frequency
-
Ongoing charge
1.13%
Latest actual NAV date
13-11-2026
ISIN
LU1934454544
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 10.56 |
| Johnson & Johnson | 9.26 |
| UnitedHealth Group Inc | 6.05 |
| Merck & Co Inc | 6.05 |
| Roche Holding AG Ordinary Shares new | 5.72 |
| Novartis AG Registered Shares | 4.49 |
| Gilead Sciences Inc | 4.07 |
| AstraZeneca PLC | 4.06 |
| Vertex Pharmaceuticals Inc | 3.70 |
| Cencora Inc | 2.76 |
Investment objective
The Portfolio seeks to increase the value of investment over time through capital growth. Under normal market conditions, the Portfolio typically invests at least 80%, and not less than two thirds, of its assets in equity securities of companies in health care and health care-related industries. These companies may be located anywhere in the world, including Emerging Markets. The Portfolio may be exposed to any currency.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.